Research News

lizabeth Rivera Rosario fits the eye reading device in front of Wei Bo.

New hearing loss test checks the eyes — not the ears
12/8/25
UB spinout Auspex Medix advances AI-powered hearing test to help older adults thwart cognitive decline, Alzheimer’s and more.

12/8/25 Read more

Study examines recovery from natural disasters
11/21/18
UB-led research found that organizations with broad social ties can improve economic outcomes for communities hit by storms, fires and quakes.
College students choose smartphones over food
11/19/18
Research by UB doctoral student Sara O'Donnell is the first to demonstrate that smartphone use is a reinforcing behavior.
Nonprescription use of Ritalin may cause changes in brain
11/19/18
As the use of Ritalin rises among those without ADHD symptoms, a CRIA study warns that such use may cause irreversible structural changes in the brain.
Gene mutation found to cause neurological disorder
11/15/18
The discovery builds on decades of work on a family of proteins by UB's Richard Gronostajski.
Freshwater mussels endure. How?
11/14/18
Surveys in the Great Lakes and Mississippi River watersheds show steady numbers of the imperiled mollusks, but other species are disappearing.
Citizenship question undermines census
11/13/18
UB sociologist Robert Adelman warns that the query would undercut the accuracy of the count and politicize the process.
Studying effects of prenatal alcohol, smoking, drug use
11/8/18
Four researchers from the Clinical Research Institute on Addictions have received more than $4 million in grants from the NIH.
Clergy adjust ‘privilege’ for peers accused of sex abuse
11/8/18
UB law professor Christine Bartholomew’s research finds a double standard when it comes to clergy divulging sensitive information.
Identifying patients at risk for opioid use
11/7/18
UB's Clinical and Research Institute on Addictions will work with OASAS to assess what risks may occur for people with alcohol use disorder who use prescription painkillers.
JDRF award continues diabetes drug research
11/6/18
The major interventional study being launched by UB scientists could help bring drugs used to treat Type 2 diabetes closer to FDA approval for Type 1.

Next> <Previous